16 results on '"Choi, Natalie K."'
Search Results
2. Mo1862 RISANKIZUMAB TREATMENT IN INFLAMMATORY BOWEL DISEASE PATIENT WITH PSORIASIS: REAL-WORLD DATA
3. Mo1848 UPADACITINIB IS EFFECTIVE AND SAFE FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE: 1-YEAR PROSPECTIVE REAL-WORLD EXPERIENCE
4. Su1750 PATIENTS IN TRIALS OF MODERATE-TO-SEVERE UC WHO ARE EXPOSED TO PLACEBO ARE MORE LIKELY TO SUFFER HARM THAN THOSE RECEIVING ACTIVE TREATMENT: THE LACK OF CLINICAL EQUIPOISE IN TRADITIONAL STUDY DESIGNS
5. Su1749 PATIENTS IN TRIALS OF MODERATE-TO-SEVERE CD WHO ARE EXPOSED TO PLACEBO ARE MORE LIKELY TO SUFFER HARM THAN THOSE RECEIVING ACTIVE TREATMENT: THE LACK OF CLINICAL EQUIPOISE IN TRADITIONAL STUDY DESIGNS
6. Sa1832 INCIDENCE OF PERIANAL COMPLICATIONS IN CLINICAL TRIALS FOR THERAPIES FOR MODERATE TO SEVERE INFLAMMATORY BOWEL DISEASE
7. Sa1804 PREVALENCE AND CLINICAL OUTCOMES IN PATIENTS WITH MUCOSAL EOSINOPHILIA IN ULCERATIVE COLITIS
8. Sa1776 INTESTINAL ULTRASOUND IS PREDICTIVE OF DISEASE RELAPSE IN ASYMPTOMATIC INFLAMMATORY BOWEL DISEASE PATIENTS
9. Sa1762 THE CHICAGO MESENTERIC FAT INDEX: A NOVEL SCALE FOR POINTOF-CARE INTESTINAL ULTRASOUND ASSESSMENT OF MESENTERIC FAT WRAPPING IN CROHN'S DISEASE IS RELIABLE AND PREDICTIVE OF DISEASE BEHAVIOR
10. Sa1757 IMPACT OF UPADACITINIB ON CARDIOVASCULAR EVENTS AND ON LIPID VALUES IN OLDER INFLAMMATORY BOWEL DISEASE PATIENTS WITH CARDIOVASCULAR RISK FACTORS
11. 1177 RISANKIZUMAB EFFECTIVENESS IN USTEKINUMAB-NAIVE AND USTEKINUMAB EXPERIENCED PATIENTS WITH CHROHN'S DISEASE: REAL WORLD DATA FROM A LARGE TERTIARY CENTER
12. 245 MONITORING IBD BY INTESTINAL ULTRASOUND DECREASES TIME TO TREATMENT CHANGE AND TIME TO REMISSION IN COMPARISON TO CONVENTIONAL MANAGEMENT: ANALYSIS OF PATIENTS WITH IBD ON MULTIPLE IBD THERAPIES
13. 317 WEARABLE PERSPIRATION SENSOR FOR CONTINUOUS INFLAMMATION TRACKING IN INFLAMMATORY BOWEL DISEASE
14. Tu1803 REAL WORLD EFFECTIVENESS AND SAFETY OF OZANIMOD: ONE-YEAR FOLLOW-UP FROM A LARGE TERTIARY CENTER
15. Tu1791 UPADACITINIB IS EFFECTIVE AND SAFE IN TOFACITINIB-EXPERIENCED PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-WORLD EXPERIENCE
16. Tu1784 UPADACITINIB IS EFFECTIVE AND SAFE FOR CROHN'S DISEASE: PROSPECTIVE REAL-WORLD EXPERIENCE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.